Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Roblin

Showing results (81-90 of 252) with videos related to

Pageof 26
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 10, 2016
French national consensus clinical guidelines for the management of ulcerative colitisLaurent Peyrin-Biroulet, Yoram Bouhnik, Xavier Roblin, et al.
Biomedicines|January 25, 2025
Avolition Characterizes the Chronic Fatigue Experienced in Quiescent Inflammatory Bowel DiseaseTristan Gabriel-Segard, Margherita Boltri, Mathilde Barrau, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 5, 2024
Risankizumab Concentration but not IL-22 Levels Are Associated With Clinical and Biochemical Remission in Patients With Crohn's DiseaseXavier Roblin, Estelle Moschetti, Mathilde Barrau, et al.
Medecine Sciences : M/S|December 18, 2015
[Key role played by the gut associated lymphoid tissue during human immunodeficiency virus infection]Delphine Vergnon-Miszczycha, Frédéric Lucht, Xavier Roblin, et al.
Digestive Diseases and Sciences|June 28, 2018
Comparison of Point-of-Care and Classical Immunoassays for the Monitoring Infliximab and Antibodies Against Infliximab in IBDYara Nasser, Rémi Labetoulle, Ines Harzallah, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 15, 2017
French national consensus clinical guidelines for the management of Crohn's diseaseLaurent Peyrin-Biroulet, Yoram Bouhnik, Xavier Roblin, et al.
Immunotherapy Advances|April 23, 2025
Development and evaluation of two whole-blood flow cytometry protocols for monitoring patients treated with JAK inhibitorsLouis Waeckel, Chloé Talon, Mathilde Barrau, et al.
Journal of Clinical Medicine|August 29, 2020
Point-of-Care Assays Could Be Useful for Therapeutic Drug Monitoring of IBD Patients in a Proactive Strategy with AdalimumabMohamad Cherry, Dominique Dutzer, Yara Nasser, et al.
Therapeutic Drug Monitoring|November 16, 2018
Evaluation of Infliximab and Anti-infliximab LISA-TRACKER Immunoassays for the Therapeutic Drug Monitoring of SB2 Infliximab BiosimilarAlexandre Jentzer, Anne-Emmanuelle Berger, Rémi Labetoulle, et al.
Endoscopy|June 5, 2019
Gastrointestinal anastomosis using a new lumen-apposing metal stent for biliary drainage is a good option in the palliative settingN Soukaïna Chawki, Bertrand Leroy, Bachir Hag, et al.
Pageof 26

Showing results (81-90 of 252) with videos related to

Sort By:
Pageof 26
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 10, 2016
French national consensus clinical guidelines for the management of ulcerative colitisLaurent Peyrin-Biroulet, Yoram Bouhnik, Xavier Roblin, et al.
Biomedicines|January 25, 2025
Avolition Characterizes the Chronic Fatigue Experienced in Quiescent Inflammatory Bowel DiseaseTristan Gabriel-Segard, Margherita Boltri, Mathilde Barrau, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 5, 2024
Risankizumab Concentration but not IL-22 Levels Are Associated With Clinical and Biochemical Remission in Patients With Crohn's DiseaseXavier Roblin, Estelle Moschetti, Mathilde Barrau, et al.
Medecine Sciences : M/S|December 18, 2015
[Key role played by the gut associated lymphoid tissue during human immunodeficiency virus infection]Delphine Vergnon-Miszczycha, Frédéric Lucht, Xavier Roblin, et al.
Digestive Diseases and Sciences|June 28, 2018
Comparison of Point-of-Care and Classical Immunoassays for the Monitoring Infliximab and Antibodies Against Infliximab in IBDYara Nasser, Rémi Labetoulle, Ines Harzallah, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 15, 2017
French national consensus clinical guidelines for the management of Crohn's diseaseLaurent Peyrin-Biroulet, Yoram Bouhnik, Xavier Roblin, et al.
Immunotherapy Advances|April 23, 2025
Development and evaluation of two whole-blood flow cytometry protocols for monitoring patients treated with JAK inhibitorsLouis Waeckel, Chloé Talon, Mathilde Barrau, et al.
Journal of Clinical Medicine|August 29, 2020
Point-of-Care Assays Could Be Useful for Therapeutic Drug Monitoring of IBD Patients in a Proactive Strategy with AdalimumabMohamad Cherry, Dominique Dutzer, Yara Nasser, et al.
Therapeutic Drug Monitoring|November 16, 2018
Evaluation of Infliximab and Anti-infliximab LISA-TRACKER Immunoassays for the Therapeutic Drug Monitoring of SB2 Infliximab BiosimilarAlexandre Jentzer, Anne-Emmanuelle Berger, Rémi Labetoulle, et al.
Endoscopy|June 5, 2019
Gastrointestinal anastomosis using a new lumen-apposing metal stent for biliary drainage is a good option in the palliative settingN Soukaïna Chawki, Bertrand Leroy, Bachir Hag, et al.
Pageof 26